Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07463664Recruiting
Drug-coated balloons for blocked heart arteries
This trial tests whether a drug-coated balloon, used without a permanent stent, can safely open completely blocked heart arteries that have been blocked for at least 3 months. It may offer an option that avoids leaving a metal stent behind.
Beijing, Beijing MunicipalityAges 18–80 - NCT07469683RecruitingPhase 2
Combination therapy for advanced kidney cancer after first-line treatment
This trial tests a combination of two drugs (SLC-3010 and axitinib) versus axitinib alone for people with advanced clear cell kidney cancer that has progressed after initial treatment. It aims to see if the combination is safer and more effective.
SeoulAges 19 years+ - NCT07468383Recruiting
Catheter ablation for slow heart rate study
This study tests a catheter procedure to treat a slow heart rate (bradycardia) that causes symptoms like dizziness or fainting. It may be an option for people who haven't had a pacemaker and whose heart can still speed up with medication.
Beijing, ChinaAges 18–65 - NCT07467122RecruitingPhase 1
TCR-T cell therapy for MAGE-A4-positive sarcomas and other tumors
This trial tests a personalized cell therapy called TCR-T that targets a protein called MAGE-A4 on tumor cells. It is for people with advanced sarcomas or similar cancers that have not responded to standard treatments.
Guangzhou, GuangdongAges 18–75 - NCT07465978Recruiting
Testing printed hybrid resin for dental overlays
This trial tests a special printed material used for tooth overlays (caps that cover the entire top of a back tooth). If you need a full overlay on a molar that has had root canal treatment, this study may be a good fit.
Sant Cugat del Vallès, BarcelonaAges 18 years+ - NCT07470073RecruitingEarly Phase 1
Universal CAR-T cell therapy for B-cell leukemia (ages 12-75)
This trial tests a new type of CAR-T cell therapy (called universal CAR-T) that targets CD19 and CD20 markers on cancer cells. It is for people aged 12 to 75 with B-cell acute lymphoblastic leukemia that has not responded to standard treatments or has come back after treatment.
Wuhan, HubeiAges 12–75 - NCT07467720Recruiting
Study on reducing radiation in peripheral artery procedures
This trial is for the interventional care team, not patients, testing a device that may reduce radiation exposure during planned leg artery procedures.
Plano, TexasAges Any age - NCT07468136RecruitingPhase 1/Phase 2
Retifanlimab with or without DFMO for progressive high-grade gliomas
This study tests a combination of two drugs—retifanlimab (an immunotherapy that helps your immune system fight cancer) and DFMO (a medicine that may stop tumor growth)—in people with high-grade brain tumors that are growing. Participants will receive these treatments before and after their planned surgery.
Rochester, MinnesotaAges 18 years+ - NCT07464379Recruiting
Study on blood pressure during pregnancy
This study looks at pregnancy-induced hypertension (high blood pressure) in pregnant women. It aims to understand how this condition affects health and to find better ways to manage it.
Wenzhou, ZhejiangAges 20–50 - NCT07463209Recruiting
Learning to use continuous glucose monitoring in diabetes education
This study helps older adults with diabetes learn how to use a continuous glucose monitor (CGM), a small device that tracks blood sugar levels in real time. You'll get education and support to manage your diabetes better, and you may have a care partner join you.
Chapel Hill, North CarolinaAges 65 years+ - NCT07471464Recruiting
Surgery prep counseling and patient satisfaction study
This study looks at whether extra counseling before surgery helps patients feel more satisfied. It includes people who are having surgery and can use MyChart.
Cleveland, OhioAges 18 years+ - NCT07470151Recruiting
Study of EVM18001 for hard-to-treat autoimmune diseases
This trial tests a new treatment, EVM18001, for people with lupus, myasthenia gravis, or systemic sclerosis that hasn't improved with standard therapies. It aims to see if this therapy can help control the disease.
Wuhan, HubeiAges 18–70 - NCT07469566Recruiting
Studying the natural course of 7q11.23 microduplication syndrome
This study follows people with a rare genetic condition called 7q11.23 microduplication over time to understand how it affects development, learning, and health. Participants will have interviews, thinking and memory tests, and an MRI brain scan.
BronAges 5–50 - NCT06791083RecruitingPhase 2
Envafolimab, Fruquintinib, and chemo before gastric cancer surgery
This trial tests a combination of two targeted drugs (Envafolimab and Fruquintinib) plus chemotherapy given before surgery for certain types of stomach cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
Fuzhou, FujianAges 18–75 - NCT06791005RecruitingPhase 3
Timing of carbon nanoparticles injection for thyroid cancer
This trial tests whether the timing of a carbon nanoparticle injection during thyroid cancer surgery improves outcomes. It may help patients who need their whole thyroid removed and have cancer in both lobes or spread to lymph nodes.
Xi'an, ShaanxiAges 16–80 - NCT06104384Recruiting
Chronic pain patients with injury claims study
This study looks at injury claims from people with chronic pain to better understand their experiences. It may help improve care for others with similar conditions.
Surrey, British ColumbiaAges 20–99 - NCT06790979Recruiting
Sleep patterns and recovery after traumatic brain injury
This study uses a wearable device to track sleep patterns in people who have had a traumatic brain injury (TBI). It aims to see how sleep relates to recovery, which could help improve care after a head injury.
Yinchuan, NingxiaAges 18–60 - NCT06792214RecruitingPhase 4
Testing if antivirals prevent long-term heart problems after COVID-19
This study tests whether two antiviral medications, Paxlovid and Veklury (remdesivir), can reduce the risk of long-term heart and blood vessel problems after a COVID-19 infection. It is for adults recently hospitalized with COVID-19 who are not currently on oxygen therapy.
Kingston, OntarioAges 18 years+ - NCT05618002Recruiting
Study compares sleep medicines for chronic pain insomnia
This trial tests different treatments to help people with long-term (chronic) pain and severe insomnia sleep better. It’s looking at three options—one medicine (lemborexant) compared with existing sleep medicines (zopiclone and clonidine)—and whether they improve sleep when non-medicine sleep strategies haven’t worked.
Surrey, British ColumbiaAges 20–99 - NCT05876117Recruiting
Pre-medication to help claustrophobic patients complete MRI
This trial tests whether a pre-medicine approach can help people with claustrophobia successfully complete an MRI scan. It may help you avoid having to stop early due to anxiety or panic in the scanner.
Surrey, British ColumbiaAges 20–99 - NCT05946850Recruiting
Caudal pain block study for adults with chronic pain
This trial looks at giving a specific pain procedure called caudal analgesia to adults with long-term (chronic) pain. It may help reduce pain after the procedure, and it will compare results for people who can safely receive it.
Surrey, British ColumbiaAges 20–99 - NCT05883358Recruiting
Treating kratom withdrawal with clonidine or buprenorphine
This trial studies medicines (clonidine and/or buprenorphine) to help manage kratom dependence and kratom withdrawal symptoms. You may be asked to regularly track withdrawal symptoms in diaries to help the study team monitor safety and response.
Surrey, British ColumbiaAges 20–99 - NCT05862454Recruiting
Magnesium shots may help avoid steroid during certain immune health issues
This trial studies whether giving a magnesium injection can replace (or avoid) steroids during treatment around times of vaccine, a viral infection, or immune system weakness. It targets adults with long-term (chronic) pain who already receive injection-based treatments and can reliably track symptoms.
Surrey, British ColumbiaAges 20–99 - NCT05945719Recruiting
Study on harassment discrimination against pain staff
This study focuses on adult people living with chronic pain. It may be looking at how patient behavior and workplace discrimination or harassment affect pain care staff.
Surrey, British ColumbiaAges 20–99
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.